154 related articles for article (PubMed ID: 33175195)
21. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma.
Kinney SN; Eble JN; Hes O; Williamson SR; Grignon DJ; Wang M; Zhang S; Baldrige LA; Martignoni G; Brunelli M; Wang L; Comperat E; Fan R; Montironi R; MacLennan GT; Cheng L
Mod Pathol; 2015 Sep; 28(9):1236-48. PubMed ID: 26248896
[TBL] [Abstract][Full Text] [Related]
22. [Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma].
Lyu JJ; Kong YY; Cai X; Shen XX; Lu YW; Ren M
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):548-552. PubMed ID: 28810295
[No Abstract] [Full Text] [Related]
23. Metanephric adenoma with low apparent diffusion coefficient value mimicking renal cell carcinoma: A case report.
Chang CB; Ng KF; Wong YC; Lee SY; Chuang CK; Wang LJ
Medicine (Baltimore); 2018 Dec; 97(49):e13539. PubMed ID: 30544462
[TBL] [Abstract][Full Text] [Related]
24. A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.
Huang WK; Kuo TT; Wu CE; Cheng HY; Hsieh CH; Hsieh JJ; Shen YC; Hou MM; Hsu T; Chang JW
Asia Pac J Clin Oncol; 2016 Dec; 12(4):403-408. PubMed ID: 27488807
[TBL] [Abstract][Full Text] [Related]
25. Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.
Lasota J; Kowalik A; Wasag B; Wang ZF; Felisiak-Golabek A; Coates T; Kopczynski J; Gozdz S; Miettinen M
Am J Surg Pathol; 2014 Sep; 38(9):1235-41. PubMed ID: 24832158
[TBL] [Abstract][Full Text] [Related]
26. [Metanephric Adenoma : A Report of Two Cases].
Kayano S; Sasaki H; Kimura T; Egawa S
Hinyokika Kiyo; 2018 Aug; 64(8):329-333. PubMed ID: 30369221
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
Kuan SF; Navina S; Cressman KL; Pai RK
Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
[TBL] [Abstract][Full Text] [Related]
28. Metanephric Adenoma in the Pediatric Population: Diagnostic Challenges and Follow-up.
Benson M; Lee S; Bhattacharya R; Vasy V; Zuberi J; Yasmeen S; Ahmed M; Hanna MK
Urology; 2018 Oct; 120():211-215. PubMed ID: 30006267
[TBL] [Abstract][Full Text] [Related]
29. Embryonal Origin of Metanephric Adenoma and its Differential Diagnosis.
Sarlos DP; Banyai D; Peterfi L; Szanto A; Kovacs G
Anticancer Res; 2018 Dec; 38(12):6663-6667. PubMed ID: 30504374
[TBL] [Abstract][Full Text] [Related]
30. CT and ultrasound findings of metanephric adenoma: a report of two cases and literature review.
Zhang LJ; Yang GF; Shen W; Lu GM
Br J Radiol; 2011 Mar; 84(999):e51-4. PubMed ID: 21325357
[TBL] [Abstract][Full Text] [Related]
31. Metanephric adenoma in a 6-year-old child with hemihypertrophy.
Küpeli S; Baydar DE; Canakl F; Yalçn B; Kösemehmetoğlu K; Tekgül S; Büyükpamukçu M
J Pediatr Hematol Oncol; 2009 Jun; 31(6):453-5. PubMed ID: 19648796
[TBL] [Abstract][Full Text] [Related]
32. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K.
Han F; Zhang L; Zhang S; Zhou H; Yi X
Int J Clin Exp Pathol; 2015; 8(5):5896-901. PubMed ID: 26191315
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological features and differential diagnosis of metanephric adenoma: a report of sixteen cases].
Xi CG; Fan Y; Yang XY; Liu LB; Wang JH; Hu S; Li YY; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):598-602. PubMed ID: 29263496
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
[TBL] [Abstract][Full Text] [Related]
35. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases.
Ding Y; Wang C; Li X; Jiang Y; Mei P; Huang W; Song G; Wang J; Ping G; Hu R; Miao C; He X; Chen G; Li H; Zhu Y; Zhang Z
Diagn Pathol; 2018 Aug; 13(1):54. PubMed ID: 30111351
[TBL] [Abstract][Full Text] [Related]
36. Metanephric adenoma of the kidney: a case report.
Navarro O; Conolly B; Taylor G; Bägli DJ
Pediatr Radiol; 1999 Feb; 29(2):100-3. PubMed ID: 9933328
[TBL] [Abstract][Full Text] [Related]
37. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
38. Metanephric adenoma: molecular study and review of the literature.
Rodríguez-Zarco E; Machuca-Aguado J; Macías-García L; Vallejo-Benítez A; Ríos-Martín JJ
Oncotarget; 2022; 13():387-392. PubMed ID: 35198098
[TBL] [Abstract][Full Text] [Related]
39. Paediatric metanephric tumours: a clinicopathological and molecular characterisation.
de Jel DVC; Hol JA; Ooms AHAG; de Krijger RR; Jongmans MCJ; Littooij AS; Drost J; van Grotel M; van den Heuvel-Eibrink MM
Crit Rev Oncol Hematol; 2020 Jun; 150():102970. PubMed ID: 32371339
[TBL] [Abstract][Full Text] [Related]
40. [Metanephric adenoma: report of two cases].
Terao H; Matsumoto T; Umemoto S; Onuki T; Kobayashi K; Ohgo Y; Nogcchi S; Kishi H; Tsuura Y; Nagashima Y
Hinyokika Kiyo; 2008 Sep; 54(9):599-602. PubMed ID: 18975573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
